Press Releases

 
Press Releases
  Date Title View
Jan 23, 2017
Plans to Apply for Orphan Drug Designation RADNOR, Pa., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Marinus Phar...
Jan 5, 2017
Several Data Milestones Anticipated With Ganaxolone RADNOR, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) -- ...
Jan 3, 2017
RADNOR, Pa., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated ...
Nov 15, 2016
Data Presented at Neuroscience 2016 RADNOR, Pa., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuti...
Nov 3, 2016
RADNOR, Pa., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to ...
Oct 19, 2016
Data Presented at the 141st Annual Meeting of the American Neurological Association RADNOR, Pa., Oct. 19, 2016 (GLOBE NEWSWIRE) -- ...
Sep 29, 2016
RADNOR, Pa., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Sep 7, 2016
RADNOR, Pa., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Aug 9, 2016
RADNOR, Pa., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated ...
Jun 28, 2016
Anxiety and Hyperactivity Benefit shown in FXS Children Study Investigator to Participate in Conference Call and Webcast Today at 9:00 a.m. ET  RADNOR, Pa., June 28, 2016 (GLOBE NEWSWIRE) -- ...
FirstPrevious
2
...
NextLast
= add release to Briefcase